Gene · 3635
Papers3,499
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,499
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Flt3L/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy. | Cancers (Basel) | 2021 | 33810248 | PubTator, text mining | PubMed |
| Covalent Cysteine Targeting of Bruton's Tyrosine Kinase (BTK) Family by Withaferin-A Reduces Survival of Glucocorticoid-Resistant Multiple Myeloma MM1 Cells. | Cancers (Basel) | 2021 | 33807411 | PubTator, text mining | PubMed |
| Targeting AKT/mTOR and Bcl-2 for Autophagic and Apoptosis Cell Death in Lung Cancer: Novel Activity of a Polyphenol Compound. | Antioxidants (Basel) | 2021 | 33805467 | PubTator, text mining | PubMed |
| Broad Metabolome Alterations Associated with the Intake of Oral Contraceptives Are Mediated by Cortisol in Premenopausal Women. | Metabolites | 2021 | 33805221 | PubTator, text mining | PubMed |
| 13R,20-Dihydroxydocosahexaenoic Acid, a Novel Dihydroxy- DHA Derivative, Inhibits Breast Cancer Stemness through Regulation of the Stat3/IL-6 Signaling Pathway by Inducing ROS Production. | Antioxidants (Basel) | 2021 | 33804152 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Cancer Diagnosis and Therapy: Focus on Lung Cancer. | Cancers (Basel) | 2021 | 33803619 | PubTator, text mining | PubMed |
| Searching the Dark Genome for Alzheimer's Disease Risk Variants. | Brain Sci | 2021 | 33800766 | PubTator, text mining | PubMed |
| MicroRNAs as crucial mediators in the pharmacological activities of triptolide (Review). | Exp Ther Med | 2021 | 33791008 | PubTator, text mining | PubMed |
| A 10-year follow-up of key gas exchange exercise parameters in a general population: results of the Study of Health in Pomerania. | ERJ Open Res | 2021 | 33778050 | PubTator, text mining | PubMed |
| Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game. | Front Immunol | 2021 | 33763063 | PubTator, text mining | PubMed |
| The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation. | Front Immunol | 2021 | 33746972 | PubTator, text mining | PubMed |
| Neurodegenerative phosphoprotein signaling landscape in models of SCA3. | Mol Brain | 2021 | 33741019 | PubTator, text mining | PubMed |
| APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease. | Front Neurosci | 2021 | 33732104 | PubTator, text mining | PubMed |
| Surface Proteomics Reveals CD72 as a Target for In Vitro-Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL. | Cancer Discov | 2021 | 33727310 | PubTator, text mining | PubMed |
| Allosteric Site on SHIP2 Identified Through Fluorescent Ligand Screening and Crystallography: A Potential New Target for Intervention. | J Med Chem | 2021 | 33724834 | PubTator, text mining | PubMed |
| Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage. | Virulence | 2021 | 33724154 | PubTator, text mining | PubMed |
| Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma. | Exp Hematol Oncol | 2021 | 33722306 | PubTator, text mining | PubMed |
| Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1. | Front Immunol | 2021 | 33717088 | PubTator, text mining | PubMed |
| Dysregulation of Phosphoinositide 5-Phosphatases and Phosphoinositides in Alzheimer's Disease. | Front Neurosci | 2021 | 33716646 | PubTator, text mining | PubMed |
| Assessing the costs and environmental benefits of IMO regulations of ship-originated SOx and NOx emissions in the Baltic Sea. | Ambio | 2021 | 33677810 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3635/papers?page=50